Peter Feinberg - Mar 18, 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Stock symbol
IMRX
Transactions as of
Mar 18, 2024
Transactions value $
$183,058
Form type
4
Date filed
3/19/2024, 07:04 PM
Previous filing
Jan 26, 2024
Next filing
Mar 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $104K +45K +382.66% $2.31 56.8K Mar 18, 2024 Direct F1
transaction IMRX Class A Common Stock Purchase $15.2K +4.98K +8.76% $3.05 61.8K Mar 18, 2024 Direct F2
transaction IMRX Class A Common Stock Purchase $64K +25K +40.48% $2.56 86.8K Mar 19, 2024 Direct
holding IMRX Class A Common Stock 392K Mar 18, 2024 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 477K Mar 18, 2024 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115K Mar 18, 2024 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.96 to $2.9499. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
F2 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.9863 to $3.1799. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.